Moreover, the IGF-1/IGF-1 receptor axis has also been shown to be involved in the increased risk of early-onset breast cancers in women with mutations in the Breast Cancer Susceptibility gene (BRCA1). This evidence concerns the gene IGF1 and breast carcinoma.